An organ-preserving approach to muscle-invading transitional cell cancer of the bladder (Q34259460)

1 August 2017

1 reference

title

An organ-preserving approach to muscle-invading transitional cell cancer of the bladder (English)

1 reference

1 August 2017

Brown AL Jr

1

1 reference

1 August 2017

Zietman AL

series ordinal

2

1 reference

1 August 2017

Shipley WU

series ordinal

3

1 reference

1 August 2017

Kaufman DS

series ordinal

4

1 reference

1 August 2017

publication date

1 April 2001

1 reference

Hematology / Oncology Clinics of North America

1 August 2017

published in

1 reference

1 August 2017

volume

15

1 reference

1 August 2017

issue

2

1 reference

1 August 2017

page(s)

345-58, vii

1 reference

Cisplatin and radiation: interaction probabilities and therapeutic possibilities

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970216-1

7 January 2021

Local recurrence and survival following nerve-sparing radical cystoprostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970216-1

7 January 2021

Radiotherapy for T2 and T3 carcinoma of the bladder: the influence of overall treatment time.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970216-1

7 January 2021

Organ-sparing treatment of advanced bladder cancer: a 10-year experience

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970216-1

7 January 2021

Curative radiotherapy following chemotherapy for invasive bladder carcinoma (a preliminary report)

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970216-1

7 January 2021

Additive effects of cisplatin and radiation in human tumor cells under oxic conditions

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970216-1

7 January 2021

Local recurrence after cystectomy alone for bladder carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970216-1

7 January 2021

Does neoadjuvant cisplatin-based chemotherapy improve the survival of patients with locally advanced bladder cancer: a meta-analysis of individual patient data from randomized clinical trials. Advanced Bladder Cancer Overview Collaboration

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970216-1

7 January 2021

Radical radiotherapy for muscle invasive transitional cell carcinoma of the bladder: failure analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970216-1

7 January 2021

The place of radiation therapy as definitive treatment of bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970216-1

7 January 2021

Cancer statistics, 2000.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970216-1

7 January 2021

Treatment of invasive bladder cancer by local resection and high dose methotrexate

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970216-1

7 January 2021

Quality of life after radical cystectomy for bladder cancer in patients with an ileal conduit, cutaneous or urethral kock pouch

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970216-1

7 January 2021

Comparison of transurethral resection to radical therapies for stage B bladder tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970216-1

7 January 2021

Conservative management of muscle-infiltrating bladder cancer: prospective experience.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970216-1

7 January 2021

Combined radiation and chemotherapy for invasive transitional-cell carcinoma of the bladder: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970216-1

7 January 2021

Systemic Therapy for Invasive Bladder Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970216-1

7 January 2021

Reappraisal of the role of radical radiotherapy and salvage cystectomy in the treatment of invasive (T2/T3) bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970216-1

7 January 2021

Bladder preservation by combined modality therapy for invasive bladder cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970216-1

7 January 2021

The quality of life after radical radiotherapy for bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970216-1

7 January 2021

Systemic preoperative chemotherapy with cisplatin, methotrexate and vinblastine for locally advanced bladder cancer: local tumor response and early followup results

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970216-1

7 January 2021

Five-year followup of a prospective trial of radical cystectomy and neoadjuvant chemotherapy: Nordic Cystectomy Trial I. The Nordic Cooperative Bladder Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970216-1

7 January 2021

Analysis of failure following definitive radiotherapy for invasive transitional cell carcinoma of the bladder

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970216-1

7 January 2021

Bladder cancer.Superiority of preoperative irradiation and cystectomy in clinical stages B2 and C

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970216-1

7 January 2021

Results of contemporary radical cystectomy for invasive bladder cancer: a clinicopathological study with an emphasis on the inadequacy of the tumor, nodes and metastases classification

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970216-1

7 January 2021

Preliminary results in invasive bladder cancer with transurethral resection, neoadjuvant chemotherapy and combined pelvic irradiation plus cisplatin chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970216-1

7 January 2021

Primary radical radiotherapy for T3 transitional cell cancer of the bladder: an analysis of survival and control

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970216-1

7 January 2021

Results of Medical Research Council phase II study of low dose cisplatin and methotrexate in the primary treatment of locally advanced (T3 and T4) transitional cell carcinoma of the bladder

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970216-1

7 January 2021

Efficacy of radiochemotherapy with platin derivatives compared to radiotherapy alone in organ-sparing treatment of bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970216-1

7 January 2021

Neo-adjuvant chemotherapy for invasive bladder cancer. Experience with the M-VAC regimen

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970216-1

7 January 2021

Neoadjuvant chemotherapy for invasive bladder cancer: prognostic factors for survival of patients treated with M-VAC with 5-year follow-up.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970216-1

7 January 2021

Adjuvant chemotherapy in T3 carcinoma of the bladder. A prospective trial: preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970216-1

7 January 2021

Phase III trial of neoadjuvant chemotherapy in patients with invasive bladder cancer treated with selective bladder preservation by combined radiation therapy and chemotherapy: initial results of Radiation Therapy Oncology Group 89-03

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970216-1

7 January 2021

Invasive bladder cancer: treatment strategies using transurethral surgery, chemotherapy and radiation therapy with selection for bladder conservation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970216-1

7 January 2021

The role of adjuvant chemotherapy following cystectomy for invasive bladder cancer: a prospective comparative trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970216-1

7 January 2021

Radical radiation treatment of invasive and locally advanced bladder carcinoma in elderly patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970216-1

7 January 2021

Advanced Bladder Cancer (Stages pT3b, pT4a, pN1 and pN2): Improved Survival after Radical Cystectomy and 3 Adjuvant Cycles of Chemotherapy. Results of a Controlled Prospective Study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970216-1

7 January 2021

Combined modality program with possible organ preservation for invasive bladder carcinoma: results of RTOG protocol 85-12

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970216-1

7 January 2021

Neoadjuvant combined modality program with selective organ preservation for invasive bladder cancer: results of Radiation Therapy Oncology Group phase II trial 8802

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970216-1

7 January 2021

Neo-adjuvant (Pre-emptive) Cisplatin Therapy in Invasive Transitional Cell Carcinoma of the Bladder

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970216-1

7 January 2021

A bladder cancer multi-institutional experience with total cystectomy for muscle-invasive bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970216-1

7 January 2021

The combination of cis-platin based chemotherapy and radiation in the treatment of muscle-invading transitional cell cancer of the bladder.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970216-1

7 January 2021

10.1016/S0889-8588(05)70216-1

Identifiers

DOI

1 reference

1 August 2017

1 reference